-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - DPN is usually described as glove-stocking distribution of numbness,
sensory loss, paresthesia (abnormal … ulcerations.14 Although DPN is not an outcome in studies
addressing these comorbid conditions, they may be described … the Review
Inclusion and exclusion criteria are provided in Table A, based on the PICOTS framework described … As described in Section A. we will assess systematic reviews with
ROBIS and, where possible, will use
-
effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
October 01, 2007 - Using the algorithm described in the methods, we
estimated propensity scores for each treatment regimen … As described in the algorithm, the expected outcome
(charges) for each strata was estimated by linear … As described
in step 3), the transitional probabilities in columns 5 and 6 were estimated by proportional … As described in step
4), the expected outcome (in this case, charges) for each strata was estimated by
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
January 30, 2012 - Inclusion/Exclusion of Studies in the Review
We will apply the inclusion and exclusion criteria described … Data needed to assess quality and applicability, as described in the Methods
Guide,25 will also be abstracted … The strength of
evidence will be assessed by using the approach described in AHRQ’s Methods Guide.25,28 … Assessing Applicability
We will assess applicability across our key questions using the method described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
November 01, 2014 - 2005 by the
American Thoracic Society (ATS)
and the Infectious Diseases Society of
America (IDSA) described … independently
reviewed each full-text article for inclusion or exclusion
based on the eligibility criteria described … Further,
methods were not clearly described. … principles and clinical trial
efficacy data.1 Nevertheless, the effectiveness of the
dosing strategies described
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
January 01, 2015 - Peer Reviewer #3 Results Are the characteristics of the studies clearly
described?
Yes. … In the ‘Summary’ column of these tables effects are
described as small, medium/moderate, and large but … We described these
studies in the text. … We made a note
of this in Table 2, where the drugs are first
described. … DPP4 inhibitors are misleadingly
described as less effective.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cervical-degenerative-protocol.pdf
January 12, 2022 - Effectiveness Reviews.32 Studies will be rated as being “low,”
“moderate,” or “high” risk of bias as described … initially assessed by one researcher for
each clinical outcome (see PICOTS) by using the approach described … noted as “no evidence”
The strength of the evidence may be downgraded based on the limitations described … existence of
plausible unmeasured confounders), if there are no downgrades on the primary domains,
as described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/treatment-resistant-depression_research-protocol.pdf
December 09, 2009 - The steps that we will take to accomplish the literature
review are described below. … independently reviewed by two members of the team for inclusion or exclusion based on
the eligibility criteria described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
November 09, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: November 9, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: Critical Analysis of the Evidence for Patient Safety Practices
I. Background and Objectives fo…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
September 01, 2014 - Strength of Evidence Grading
We used the EPC system for grading evidence on
diagnostic tests as described … concern about reporting bias, the finding
was precise, and one of the three types of conclusions
described … Settings of care were to be described,
and if data permitted, subgroups of studies by setting were … We included the remaining 130
publications, which described 123 unique studies/reviews
(seven publications … Imaging Techniques for Diagnosis and/
or Staging
We included a total of 78 studies for this KQ: 50 described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - For studies where the specific
randomization method is unclear, but the
study is described as “randomized … Is the study described as randomized?
2. … Is the study described as non-randomized?
2. Are there more than 250 subjects?
4. … efforts will be made to obtain it and the HR will be calculated
from published reports, using methods described … or in both arms not attributable to
lack of ascertainment, pooling will be performed using methods described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_disposition-comments.pdf
August 21, 2013 - On page 7, line 4-5, FACT is correctly described as
involving modification of the ACT model. … Methods: Scope and parameters of this report are well-
described and justified. … Introduction: The Key questions are clearly described. … Results Results: I thought the methodology generally and
inclusion/exclusion criteria were very well described … Discussion/ Conclusion: The implications of the findings
are well stated, and the limitations well described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
March 25, 2012 - diminished sexual function and vaginal dryness are also common.7-9 A natural history of
symptoms can be described … Current evidence supporting the safety and effectiveness of compounded
hormone therapies is generally described … therapy—published as a scientific
statement.29 Efforts to systematically review and synthesize the literature were described … colorectal, or
ovarian cancer; similar study types, duration, and size criteria will be applied as described … For the more quantitative approach, we will adapt the method described by
Thompson et al.46
E.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment_research-protocol.pdf
December 20, 2011 - Interventions
Specific psychological interventions that have been studied for the treatment of PTSD are
described … The KQs
are displayed within the PICOS context described in the previous section. … Appropriateness will be determined by the same methods described
above.
Table 4. … independently
review each full-text article for inclusion or exclusion based on the eligibility
criteria described … As described above, all results will be tracked in
an EndNote database.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
March 29, 2011 - We
anticipate that the evidence garnered from the literature search described above will
consist of … Summary of Protocol Amendments
This amendment is to clarify methods described in the protocol for the … March 29, 2011 KQ 1a &
1b
We will begin with a review of
existing reviews, using the methods
described … We anticipate that the evidence garnered from the literature search described above will consist of small … Summary of Protocol Amendments
This amendment is to clarify methods described in the protocol for the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
May 01, 2015 - The purpose of this
document is well described in the preface materials. … The purpose of these sections is now described more in the
methods and we have changed the titles for … To the extent that certain functionalities exist in both
settings, we have described them, but with … The opportunities for
clinical decision support are well described.
Thank you for your comment. … Peer Reviewer
#7
Findings This is well described and critical for children.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
October 30, 2019 - An additional problem is that
this criterion is often not interpreted as described
here: the wording … In some places there was inconsistency
in the way the results were described. … Reviewer #3 Results All types of observational studies were often
combined into a single category and described … instruments focus on stroke rates at different
scores but don’t seem to report the c-statistic which
is described … The results aren’t really described in a
parallel fashion to KQ 1, e.g. the summary bullets
don’t describe
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
February 07, 2018 - Although these latter strategies are less rigorous, they will be considered for inclusion
and described … of non-English language articles will be reviewed at the abstract stage
consistent with the process described … The appropriateness of those studies will be determined using the
methods described above.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
October 12, 2015 - the context of the population,
interventions, comparators, outcomes, timings, and settings (PICOTS) described … Data
necessary for assessing quality and applicability, as described in the Methods Guide,57 will
also … The strength
of evidence will be assessed using the approach described in the AHRQ’s Methods
Guide.57,63 … Key aspects of previous
reviews to be described include number and types of studies included, strength … Assessing Applicability
We will assess applicability across our key questions using the method described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
August 09, 2013 - liver.14 MRI can also be used as an adjunct to CT to better detect
extrahepatic disease.17,18
As described … encasement, or any distant metastases
• A “borderline” resectable tumor fits neither of the two categories described … For statistical analyses comparing the accuracy of two imaging tests, we will
use the EPC methods described … Comparisons and
Outcomes
We will use the EPC system for grading evidence on diagnostic tests as described … Settings of care will be described, and if data
permit, subgroups of studies based on setting will be
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-frameworks.ppt
June 01, 2012 - comparator, outcomes, timing, and setting) typology, analytic frameworks, and decision trees will be described … Principle 2: Develop an Analytic Framework (1 of 2)
The second principle described to address challenges … Most organizational frameworks have categories that line up with the analytic framework described in … Cases Illustrating the Five Principles
To illustrate the five principles described, three case examples … Sample Replacement Test Project: FFDM Versus SFM (2 of 4)
After using the principles described in this